Even though there is a strong evidence suggestive of benefits and safety of dual (aspirin plus clopidogrel) antiplatelet therapy, decreased responsiveness or "resistance" to mono- and/or dual antiplatelet therapy has been described in association with an increased thrombotic risk. Various mechanisms contribute to antiplatelet resistance, with abundant production of inflammatory markers being of particular importance. The current review overviews implications of inflammation in antiplatelet resistance.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2174/187152810793938017 | DOI Listing |
Publication Analysis
Top Keywords
antiplatelet resistance
12
antiplatelet therapy
8
antiplatelet
5
relationship inflammation
4
inflammation platelet
4
platelet activation
4
activation antiplatelet
4
resistance strong
4
strong evidence
4
evidence suggestive
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!